How was OCREVUS studied?
Learn more about the clinical trials behind OCREVUS.
OCREVUS for relapsing MS
OCREVUS has been proven to be effective for the treatment of
relapsing MS in 2 large, identical clinical studies against REBIF.
OCREVUS for PPMS
OCREVUS is the first approved treatment for primary progressive multiple sclerosis (PPMS).
What you should know
Take a moment to understand the possible side effects of OCREVUS and who shouldn't take it.
A different approach to treating MS
OCREVUS is thought to work differently than other MS therapies.